For example, the expression level of epidermal growth factor receptor (EGFR) in CMCs affects clinical prognosis [23]; HER-2 overexpression, occurring in about 20% of CMCs as in BC [24], or the loss of estrogen (ER) and progesterone (PR) receptors [25] are related to tumor progression. The gene discussed is EGFR; the disease is breast cancer.